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abstract 
Introduction: Annual incidence rates for oral and pharyngeal cancer are estimated at 25 cases per 100,000 in developing 
countries. Human papilloma virus (HPV) was implicated in pathogenesis of Cancer. The mutations of p53 and c-myc 
are found 50% in cancer. objective: Aims of this research were to know the incidence of OSSC patient which realized 
HPV infection without p53 and c-myc gene mutation.  materials and methods: Tissue biopsy frozen sections were 
taken from BOSC (Benign Oral Squamous Cell) and OSCC (Oral Squamous Cell Carcinoma) patients collected from 
Oral and Dental Departement of dr Muwardi Distric Hospital in Surakarta from January 2007 to January 2008. To 
amplify L1-HPV gene for fixed the HPV stressor. To amplify p53 and c-myc genes, continued with SSCP (Single 
Strand Conformational Polymorphisme) analysis and followed with measurement using densitometer, to see mutation 
existence. The collected data were analyzed with Chi Square. results: BOSC patient identified 23% with HPV infections 
and OSCC patient identified 73% with HPV infections. Hundred percent BOSC patient with HPV infection without 
mutation in p53 gene and c-myc gene, 81%  OSCC patient with HPV infection without mutation in p53 gene and 91 % 
OSCC patient with HPV infection without mutation in c-myc gene. Chi Square analysis showed significant difference 
between BOSC and OSCC patients with HPV infection without mutation in p53 and c-myc gene. conclusion: HPV is 
a factor for pathogenesis of OSCC.
abstrak 
Pendahuluan: Insidensi Infeksi HPV pada karsinoma Sel Skuamosa oral dan Hubungannya dengan mutasi 
p53 dan c-myc: Penelitian kasus kontrol pada rumah Sakit muwardi. Rata-rata angka kejadian kanker rongga 
mulut dan pharyng di negara berkembang per tahun diperkirakan pada kisaran 25 kasus per 100.000 penduduk. Saat 
ini patogenesis kanker telah diketahui berhubungan dengan virus Human papilloma (HpV). Catatan lain bahwa mutasi 
pada gena p53 dan c-myc ditemukan pada 50% dari seluruh kejadian kanker. tujuan: Tujuan penelitian ini adalah 
untuk mengetahui kejadian pasien Kanker Sel Skuamous Rongga Mulut (KSSRM) dengan infeksi HpV tanpa mutasi 
gena p53 dan c-myc.  Bahan dan cara: Jaringan biopsi frozen sections dari pasien Sel Skuamous Rongga Mulut Jinak 
(SSRMJ) dan Kanker Sel Skuamous Rongga Mulut (KSSRM) yang dikumpulkan dari Bagian Penyakit Gigi dan Mulut 
RSUD dr Muwardi Surakarta mulai Januari 2007 hingga Januari 2008. Amplifikasi gena l1-HpV untuk mengetahui 
keberadaan stressor HpV. Amplifikasi gena-gena p53 dan c-myc, dilanjutkan analisis Single Strand Comformational 
polymorphisme (SSCp) dan diikuti pengukuran menggunakan densitometer untuk melihat keberadaan mutasi. Data 
yang terkumpul dianalisa menggunakan Uji Chi Square. Hasil: Pasien SSRMJ teridentifikasi 23% terinfeksi HpV dan 
pasien KSSRM teridentifikasi 73% terinfeksi HpV. Seratus persen pasien SSRMJ yang terinfeksi HPV tercatat tanpa 
mutasi pada gena p53 dan c-myc, 81%  pasien KSSRM yang terinfeksi HpV tercatat tanpa mutasi gena p53 dan 91 % 
pasien KSSRM yang terinfeksi HPV tercatat tanpa mutasi gena c-myc. Analisis uji Chi Square menunjukkan perbedaan 
yang signifikan antara pasien SSRMJ dan KSSRM pada infeksi HpV tanpa mutasi gena p53 dan c-myc. kesimpulan: 
HpV merupakan faktor untuk kejadian KSSRM.
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Introduction
Update research found that cancer is widely perceived 
as a heterogeneous group of disorders with different 
biological properties, are caused by a series of clonally 
selected genetic changes in tumour-suppressor genes and 
oncogenes.1,2 However, recent data suggest that cancer 
has a common basis that is grounded in a polyclonal 
epigenetic disruption of progenitor cells, mediated by 
tumour-progenitor genes. Tumour cell heterogeneity is 
due in part to epigenetic variation in progenitor cells 
and epigenetic plasticity together with genetic lesions 
drives tumour progression. This crucial early role for 
epigenetic alterations in cancer is in addition to epigenetic 
alterations that can substitute for genetic variation later 
in tumour progression.2,3 Therefore, non-neoplastic but 
epigenetically disrupted might be a crucial target for 
cancer risk management. 
Cause of cancer can divide into two groups: environmental 
cause and hereditary genetic cause. Cancer is primarily 
an environmental disease, though genetics influence the 
risk of some cancers. Environmental factors include: 
environmental pollutants, diet and obesity, tobacco, 
infections, radiation, and lack of physical activity. These 
environmental factors cause or enhance abnormalities 
in the genetic of cells.3 The prevalence of oral cancer 
is increase in Africa. Annual incidence rates for oral 
and pharyngeal cancer are at 25 cases per 100,000 in 
developing countries. The urbanisation and increasing 
access to, and utilisation of tobacco in its various forms 
as well as alcohol, is to an increase in the incidence of 
oral cancer.4 Epidemiology of oral cancer are squamous 
cell represents 90% of oral cavity tumours, the incidence 
was increases with age (represent 3% of cancers in men 
and 2% of cancers in women).5 Factor that implicated as 
a potential cock and or promoter cancer were tobacco, 
alcohols, radiation of sunrise, ionization radiation, 
carcinogen related work, environment pollutant, 
medicines, nutrition and infectious agent. Another 
stressor is life in village, social-economic factor, age, 
genders and response immune mechanism. The followed 
factor is periodontal disease chronic, bed oral hygiene, 
diseases of tooth, sharp of set teeth, electrogalvanism 
and edentulism. Another researcher found that human 
papilloma virus (HPV), implicated in Oral Squamous 
Cell Carcinoma (OSCC) pathogenesis.3,6,7 Therefore, 
if the pathogenesis of OSCC can’t be explained so the 
morbidity and mortality can increase and lead to decrease 
the human resources.
The role of HPV, expression of E6 and E7 protein virus, 
expression of p53 and c-myc proteins host can explained 
by pathobiology examination8,9 in cell perception and 
cell response concept. The binding of E6 protein of 
HPV with p53 proteins lead to decrease the apoptosis. 
The other hand binding of E7 proteins with pRb protein 
lead to activate c-myc protein expression so be impact 
in decreases the proliferation. The mutations of p53 and 
c-myc are not found.10,11,12  This concept gives a chance 
to explain the increasing OSCC.
In the disease of high risk HPV infection explained the 
viral genome integrates into the host genome which is 
the necessary event for the keratinocytes immortality. 
During this process of integration the circular form of 
viral genome breaks at the level of the E1 and E2 regions. 
Different studies have shown that the integrated part of 
the genome corresponds to E1, E6 and E7. The loss of E2 
during this process of integration produces the loss of E6 
and E7 control. Therefore, the sequences E6 and E7 are 
directly involved in the cellular cycle by inhibiting the 
normal functions of p53 and pRb. The p53 can provoke 
the arrest of cellular division and assure the time necessary 
for DNA repair. If damage can’t be repaired, p53 is able 
to induce the apoptosis and prevent the propagation of 
DNA damage in subsequent generations of cells. In the 
case of other types of tumours, p53 is usually mutated and 
acts as a real oncogene. In the case of HPV infection, E6 
suppresses the properties of p53 gene product achieving the 
functional equivalent of the two hits required to knock out 
both alleles of a tumour suppressor gene. The mutations of 
p53 are normally not found. The E7 protein interacts with 
retinoblastoma protein (pRb), which is the crucial factor 
for the cellular cycle control. This interaction causes the 
release of the transcription factor E2F, which is now free 
to act and can stimulate the cellular division. E6 and E7 
can cooperate with cellular oncoproteins like ras and myc 
which enables the virus to act at the level of growth factors 
and cellular and nuclear metabolism producing oncogenic 
cells. E6 and E7 can provoke directly DNA mutations of 
the host cell. This means that certain types of HPV are 
able to cause malignant lesions even without the action of 
other cofactors.13
materials and methods
Fourty frozen section BOSC tissue and fiveteen frozen 
section OSCC tissue patients collected from Oral and 
Dental Clinic of dr Muwardi Distric Hospital in Surakarta 
from January 2007 to January 2008. Parrafin blocks were 
made from cutting I, which was subsequently stains 
with Haematoxyline Eosine (HE) to ascertain the type 
of neoplasm. 
Cutting II was subjected to Deoxyribonucleic Acid 
(DNA) isolation was made by Henk Schmits method with 
some modifications. Cut up to 25 mgr of tissue into small 
pieces, place in 1.5 ml a microfuge tube volume, and add 
200 ul of DNA extraction buffer. Add 20 ul of Proteinase 
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K stock solution, mix by vortexing, and incubate at 550 
C overnight.14
The DNA isolation results were subjected to Polymerase 
Chains Reaction (PCR) to amplify L1-HPV for fixed the 
HPV stressor. Diagnose related HPV infections are made 
by Henk Schmits and/or Nigel McMillan and Nina Fowler 
PCR-method with some modifications.14,15  Twenty five 
µl microfuge tube Ready To Go PCR Bead (Amersham 
Pharmacia Biotech) mixed with 2 µl HPV consensus 
primers (MY09: 5’GC(A/C)CAGGG(A/T)CATAA(C/T)AATGC3’ 
and MY11: 5’CGTCC(A/C)A(A/G)(A/G)GGA(A/T)ACTATC3’) 
(CYBERGENE AB) and 2 µl DNA template. PCR protocol 
for both amplifications are 940 C for 50 seconds, 590 C 
for 50 seconds, 720 C for 50 seconds and 40 C soak.  The 
Amplification of HPV-L-1 gene produced 450 bp long. 
Other DNA isolation results were subjected to Polymerase 
Chains Reaction (PCR) to amplify p53 and c-myc gene and 
continued Single Strand Conformational Polymorphism 
(SSCP) analysis and followed with measurement using 
densitometer to see mutation existence. To amplify of p53 
and c-myc made by Henk Schmits and/or Nigel McMillan 
and Nina Fowler PCR-method with some modifications.14,15 
Twenty five µl microfuge tube Ready To Go PCR Bead 
(Amersham Pharmacia Biotech) mixed with 2 µl  p53 primer 
(forward primer 5’TATCCTGAGTAGTGGTAATC3’ and 
backward primer 3’AAGTGAATCTGAGGCATAAC’) 
(Cybergene AB) and 2 µl sample DNA (template). 
The other hand twenty five µl microfuge tube Ready 
To Go PCR Bead (Amersham Pharmacia Biotech) 
mixed with 2 µl  c-myc primer (forward primer 
5’CCGTCCCTGGCTCCCCTCCTG3’ and backward 
primer 3’GTATCGTCGCCCGCCCGTTGAAAC5’) 
(Cybergene AB) and 2 µl sample DNA (template). PCR 
protocol for both amplifications are 940 C for 50 seconds, 
590 C for 50 seconds, 720 C for 50 seconds and 40 C soak. 
The Amplification of p53 gene produced 216bp and c-myc 
gene produced 347bp. Single Strand Conformational 
Polymorphism (SSCP) analysis followed with measurement 
using densitometer (Shimadzu CS 930, Dual Wave Length 
Cromato Scanner) to see mutation existence. 
results
The result of this research showed that nine patient from 
40 patient BOSC identified have HPV infections (9/40 = 
23%). Eleven patient from 15 patient OSCC identified 
have HPV infections (11/15 = 73%) (Figure 1)
figure 1. Polymerase Chains Reaction (PCR) L1 – HPV 
gene, amplified 450 bp long.
Another result of this research showed that nine patient 
without mutation in p53 gene (9/9 = 100%) and 9 patient 
without mutation in c-myc gene (9/9 = 100%) after 
SSCP analysis that confirm by densitometer against nine 
patient BOSC with HPV infection. The other hand, nine 
patient without mutation in p53 gene (9/11 = 81%) and 
10 patient without mutation in c-myc gene (10/11 = 91%) 
after SSCP analysis that confirm by densitometer against 
eleven patient OSCC with HPV infection (Figure 2A, 2B, 
2C and Figure 3A, 3B, 3C)
figure 2a. Polymerase Chains Reaction (PCR) of p53 
gene, amplified 216 bp long.
figure 2B. Single Strand Conformational Polymorphism 
(SSCP) Analysis of  p53 gene
figure 2c. Measurement using densitometry to see 
mutation existence from Strand Conformational 
Polymorphism (SSCP) Analysis of  p53 gene (have 2 
pick – arrow)
figure 3a. Polymerase Chains Reaction (PCR) c-myc 
gene, amplified 347 bp long.
figure 3B. Single Strand Conformational Polymorphism 
(SSCP) Analysis of  c-myc gene
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figure 3c. Measurement using densitometry to 
see mutation existence from Strand Conformational 
Polymorphism (SSCP) Analysis of  c-myc gene (have 2 
pick – arrow).
Chi Square analyze showed have significant differences 
between BOSC and OSCC patients with HPV infection 
without mutation in p53 and c-myc gene (Table 1, 2, 3, 4)
table 1. result of the experiment in table 2X2 of p53 
protein.
no
mutation of p53 
yes
mutation of 
p53
total
OSCC with 
HPV infection
9 (81%) 2 (19%) 11 
BOSC with 
HPV infection
9 (100%) 0 9 
18 2 20
table 2. chi Square data analysis of table 1.
k.b o e (o-e) (o-e)2 (o-e)2
e
k.1.b.1 9 9.9 -0.9 0.81 0.08
k.2.b.1 2 1.1 0.9 0.81 0.73
k.1.b.2 9 8.1 0.9 0.81 0.1
k.2.b.2 0 0.9 -0.9 0.81 0.9
X2 1.81
Xt (df = 1; p<0,01) 6.63
table 3. result of the experiment in table 2X2 of cmyc 
protein.
no
mutation of 
cmyc
yes
mutation of 
cmyc
total
OSCC with 
HPV infection
10 (91%) 1 (19%) 11 
BOSC with 
HPV infection
9 (100%) 0 9 
19 1 20
table 4. chi Square data analysis of table 3.
k.b o e (o-e) (o-e)2 (o-e)2
e
k.1.b.1 10 10.45 -0.45 0.2 0.01
k.2.b.1 1 0.55 0.45 0.2 0.36
k.1.b.2 9 8.55 0.45 0.2 0.02
k.2.b.2 0 0.45 -0.45 0.2 0.44
X2 0.83
Xt (df = 1; p<0,01) 6.63
discussion
Dental caries and periodontal disease are generally 
considered to be the major oral health problems around 
the world. In developing countries of Africa, these 
appear to be neither as common nor of the same order of 
severity as in the developed world. An epidemiological 
description of a given health problem usually includes 
its prevalence, severity (morbidity, mortality) and age-
adjusted distribution in the population. Oral diseases 
known to exist in each community must be assessed in 
this way in order to develop programmes appropriate to 
community needs. Based on this form of analysis, the 
most prominent oral health problems in Africa amongst 
low socio-economic communities include Noma, 
ANUG (Acute Necrotising Ulcerative Gingivitis), oral 
cancer, the oral manifestations of HIV and AIDS, oro-
facial trauma, and dental caries. Studies have shown 
that the oral manifestations of HIV/AIDS are common. 
Candida infections, necrotizing gingivitis and oral hairy 
leukoplakia are the most common. The prevalence of oral 
cancer is also on the increase in Africa. Annual incidence 
rates for oral and pharyngeal cancer are estimated at 25 
cases per 100,000 in developing countries. The rapid 
urbanisation and increasing access to, and utilisation of 
tobacco in its various forms as well as alcohol, is leading 
to.16 So the main risk factors are tobacco abuse, smokers 
represent 90% of oral cancer patients. Other risks that 
under research are viral infection like HSV and HPV.5,6,17,18
P53 is a gene that codes for a protein that regulates the 
cell cycle and hence functions as tumor suppression. It 
is very important for cells in multicellular organisms to 
suppress cancer. P53 has been described as the guardian 
of the genome, referring to its role in conserving stability 
by preventing genome mutation. The name is due to 
its molecular mass: it is in the 53 kilodalton fraction 
of cell proteins. The human p53 gene is located on the 
seventeenth chromosome (17p13.1). It  plays an important 
role in cell cycle control and apoptosis.  Defective p53 
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could allow abnormal cells to proliferate, resulting in 
cancer.  As many as 50% of all human tumors contain p53 
mutants.18 And c-myc codes for a protein that binds to the 
DNA of other genes and is therefore a transcription factor. 
When a gene like myc is altered to cause cancer, the 
cancerous version of the gene is called an oncogene. The 
healthy version of the gene that it is derived from is called 
a proto-oncogene. Myc gene is located on chromosome 
8 in humans and encodes for a transcription factor that is 
believed to regulate expression of 15% of all genes.19,20 
This means that in addition to its role as a classical 
transcription factor. Myc also regulate global chromatin 
structure by regulating histone acetylation both in gene-
rich regions and at sites far from any known gene.21
conclusion
Virus Human papilloma (HPV) is a factor for pathogenesis 
of Oral Squamous Cell Carcinoma (OSCC).
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